Specifically, exhausted CD8+ T cells from Nr4a1-/- mice showed decreased levels of inhibitory receptors such as PD1 and TIM3, leading to enhanced anticancer immunity in various mouse cancer models. This evidence concerns the gene CD8A and cancer.